MedPath

solcitinib

Generic Name
solcitinib

GLPG0778: Multiple Ascending Oral Doses, Pharmacokinetic, Safety, and Pharmacodynamic Study

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: placebo
First Posted Date
2011-04-15
Last Posted Date
2011-10-18
Lead Sponsor
Galapagos NV
Target Recruit Count
45
Registration Number
NCT01336244
Locations
🇧🇪

SGS Stuivenberg, Antwerp, Belgium

First-in-Human Single Ascending and Multiple Dose of GLPG0778

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: placebo
First Posted Date
2011-01-17
Last Posted Date
2011-10-18
Lead Sponsor
Galapagos NV
Target Recruit Count
40
Registration Number
NCT01278108
Locations
🇧🇪

SGS Stuivenberg, Antwerp, Belgium

© Copyright 2025. All Rights Reserved by MedPath